Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07105618
Active, not recruiting Not applicable

Total Intravenous Anesthesia in Patients Undergoing Craniotomy

NCT07105618 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-10
Last updated
2026-08-24

Condition(s) studied

Anesthesia

Investigational drug(s) / intervention(s)

Dexmedetomidine →Fentanyl →Magnesium →

Dexmedetomidine: Dexmedetomidine as an adjunct to total intravenous anesthesia.

Fentanyl: Fentanyl as an adjunct to total intravenous anesthesia.

Magnesium: Magnesium sulphate as an adjunct to total intravenous anesthesia.

Study summary

Craniotomy presents true anesthetic challenges, mainly due to the need to optimize cerebral perfusion, facilitate brain relaxation, achieve rapid emergence for neurologic assessment, and minimize perioperative complications.

Eligibility

Sex
ALL
Min age
21 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Patient acceptance. * Physical status: American Society of Anesthesiologists Physical Status (ASA) 1\& II. * Body mass index ≤ 30 kg/m2. * Type of operation: elective craniotomy for brain tumor resection. * Duration of surgery: within 4 hours. Exclusion Criteria: * Patient with hemodynamic instability or anticipated postoperative mechanical ventilation. * Patients with a known history of allergy to the study drugs. * Advanced hepatic, renal, cardiovascular, and neurologic diseases. * Patients with chronic opioid use.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Zagazig university hospital Zagazig Egypt

More Zagazig University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07105618 on ClinicalTrials.gov ↗ ← All trials in Egypt